CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 143.5% based on the discounted cash flow analysis.
| Market cap | $10.61 Billion |
|---|---|
| Enterprise Value | $15.99 Billion |
| Dividend Yield | $4.97 (5.66%) |
| Earnings per Share | $4.82 |
| Beta | 0.54 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 18.21 |
|---|---|
| PEG | -35.77 |
| Price to Sales | 1.6 |
| Price to Book Ratio | 43.88 |
| Enterprise Value to Revenue | 2.38 |
| Enterprise Value to EBIT | 17.14 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7577▲ 8.00% |
|---|---|
| Total Calls | 4,051,200▲ 59.34% |
| Total Puts | 3,069,525▲ 78.15% |
Holdings and activity of institutional investors.
| Ownership % | 86.52%▲ 3.86% |
|---|---|
| Total Invested | $10.04B▼ 3.02% |
| Investors Holding | 1,096▼ 34.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...